Thats why its a good idea to talk to your doctor
Despite the potential clinical benefits of GLP-1RA plus SGLT2i combination therapy in patients with T2DM, several factors may delay this combination to become a common practice soon, such as reimbursement and costs associated with polypharmacy
Currently, have evolved from antidiabetic drugs into a platform-type therapy covering obesity, cardiovascular, and renal protection (7577)
In a statement to Insider, Novo Nordisk, the company that makes Wegovy and Ozempic, said that Gila monsters and the discovery of exendin-4 "did not have anything to do with our decision to develop long-acting GLP-1 receptor agonists" for obesity, because "that was based on GLP-1 biology in humans." But the company also said that "the GLP-1-like effect of exendin-4" in Gila monsters was "an important contribution to the field," as it led to the development of the very first injectable drug of its kind
Taking your injection at the same time each week, maintaining supportive nutrition habits , staying active, and communicating with your provider about how the medication is working
However, large-scale studies have not conclusively proven a direct link between Semaglutide and an increased risk of pancreatitis